RISE in HR NBLNCT06831552
Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 7 versions: 7 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 10 words
- Trial sites expanded: 6 → 9 locations
- Secondary endpoints: details revised at 3 of 3 entries
- Minor Study sites: 5 to 6v6
- Notable Primary endpoint revised
- Secondary endpoints revised (3)
- Site contacts updated at 1 of 5 sites
- Minor Study sites: 1 to 5v4
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Apr 2025 to Apr 30, 2025
- Site details revised
- Minor Study title shortened, about 19 wordsv2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (3)
Arms and interventions
Participants will be randomized in a 1:1 ratio and stratified according to treatment group and Household Material Hardship (HMH) severity score. Participant parents/guardians will complete: * Orientation visit in-person, by phone, or virtually with survey * Access to usual supportive oncology care comprised of social workers, resource specialists and/or psychosocial oncology teams * Meeting with a benefits counselor by phone or virtually and follow up meetings if needed * Fixed amount of cash assistance 2x monthly * 3 months survey * 6 month survey
Participants will be randomized in a 1:1 ratio and stratified according to treatment group and HMH severity score. Participant parents/guardians will complete: * Orientation visit in-person, by phone, or virtually with survey * Access to usual supportive oncology care comprised of social workers, resource specialists and/or psychosocial oncology teams * 3 month survey * 6 month survey
Behavioral: RISE Intervention
Sites
9 sites in 1 country